India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 ...
India has become one of the first countries to introduce Awiqli, the world’s first once-weekly basal insulin for adults with ...
India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...
By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...
A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...
Danish pharma major Novo Nordisk has launched 'Awiqli' in India, a once-weekly basal insulin injection for adults with ...
India Today on MSN
World's first and only once-weekly insulin launched in India
Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India. The therapy is aimed at easing ...
Novo Nordisk has launched Awiqli, a once-weekly basal insulin, in India. This innovation offers a significant reduction from ...
Novo Nordisk India is rolling out Awiqli – a weekly once basal insulin, for adults with Type 1 or Type 2 diabetes mellitus.
Awiqli offers adults with diabetes fewer injections while maintaining effective blood sugar control through weekly dosing.
Novo Nordisk says Awiqli can cut basal insulin shots from 365 to 52 a year, targeting delayed insulin use in India’s vast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results